No definition available.
Isolated proteinuria with specified morphological lesion
DOID EFO Endpoint Browser PheWeb
N14_ISOLPROTEINURIA
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
395 |
4. Check minimum number of eventsNone |
395 |
5. Include endpointsNone |
395 |
6. Filter based on genotype QC (FinnGen only) |
395 |
Control definitions (FinnGen only)
- Control exclude
- N14_GLOMERULAR
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- N00-N08
- Name in latin
- Proteinuria isolata cum laesione morphologica specificata
Similar endpoints
↥List of similar endpoints to
Isolated proteinuria with specified morphological lesion
based on the number of shared cases.
Similar with more cases:
- Glomerulonephritis
- Glomerular diseases
- Genitourinary diseases
- Any event in hilmo or specialist outpatient
- Any prescribed medicine buy
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 2409 | 1167 | 1221 |
| Only index persons | 2118 | 1030 | 1088 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.03 | 0.03 | 0.03 |
| Only index persons | 0.04 | 0.04 | 0.04 |
| Median age at first event (years) | |||
| Whole population | 57.83 | 56.49 | 59.16 |
| Only index persons | 55.61 | 53.58 | 57.53 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 395 | 193 | 202 |
| Unadjusted period prevalence (%) | 0.08 | 0.07 | 0.09 |
| Median age at first event (years) | 55.99 | 50.34 | 61.39 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 358
- Matched controls
- 3578
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
N06.9
ICD-10 Finland
Isolated proteinuria with specified morphological lesion, unspecified
+∞
217.6
186
*
N06.0
ICD-10 Finland
Isolated proteinuria with specified morphological lesion, minor glomerular abnormality
+∞
76.9
71
*
KA3AT
NOMESCO Finland
Biopsy of kidney with ultrasound guidance
309.6
75.5
74
*
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
58.9
64.5
75
16
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
17.9
64.4
105
81
R80
ICD-10 Finland
Isolated proteinuria
134.3
63.3
66
6
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
43.8
52.9
65
18
I15.1
ICD-10 Finland
Hypertension secondary to other renal disorders
129.5
52.4
55
5
N18.8
ICD-10 Finland
Other chronic renal failure
26.6
52.3
73
34
A11CC03
ATC
alfacalcidol; systemic
39.1
49.3
62
19
L04AA06
ATC
mycophenolic acid; systemic
53.9
46.6
55
12
C03CA01
ATC
furosemide; systemic
5.3
45.5
190
629
N04.9
ICD-10 Finland
Nephrotic syndrome, unspecified
+∞
44.7
42
*
Z94.0
ICD-10 Finland
Kidney transplant status
107.9
44.0
47
5
127
Kela drug reimbursment
Transplant complication
59.8
40.6
47
9
N06.1
ICD-10 Finland
Isolated proteinuria with specified morphological lesion, focal and segmental glomerular lesions
+∞
40.4
38
*
A12AA04
ATC
calcium carbonate; oral
38.5
39.7
50
15
KAS10
NOMESCO Finland
Allogenic transplantation of kidney from cadaver donor
118.5
39.7
42
*
N39.1
ICD-10 Finland
Persistent proteinuria, unspecified
205.6
36.5
37
*
TK800
NOMESCO Finland
Hemodialysis
34.9
35.8
46
15
Z49.0
ICD-10 Finland
Preparatory care for dialysis
87.4
35.6
39
5
PBL10
NOMESCO Finland
Construction of arteriovenous fistula from radial artery
72.6
34.8
39
6
190
Kela drug reimbursment
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
99.8
33.4
36
*
L04AD01
ATC
ciclosporin; systemic
32.4
32.9
43
15
N08.2*D89.80
ICD-10 Finland
Immunoglobulin A (IgA) nephropathy
+∞
32.8
31
*
N04.1
ICD-10 Finland
Nephrotic syndrome, focal and segmental glomerular lesions
+∞
32.8
31
*
137
Kela drug reimbursment
Uraemia requiring dialysis
79.6
32.5
36
5
Z49.1
ICD-10 Finland
Extracorporeal dialysis
58.7
32.0
37
7
L04AA01
ATC
[U] ciclosporin; systemic
32.9
31.5
41
14
C08CA01
ATC
amlodipine; oral
3.8
31.0
197
868
N18.0
ICD-10 Finland
End-stage renal disease
74.8
30.5
34
5
205
Kela drug reimbursment
Chronic hypertension
3.9
30.3
167
651
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
5.4
29.9
102
247
N04.0
ICD-10 Finland
Nephrotic syndrome, minor glomerular abnormality
+∞
29.6
28
*
N08.39*E11.2
ICD-10 Finland
Non-insulin-dependent diabetes mellitus - Diabetic nephropathy
+∞
29.6
28
*
B03XA02
ATC
darbepoetin alfa; parenteral
32.5
29.2
38
13
C09AA02
ATC
enalapril; systemic
4.4
28.9
127
399
N03.9
ICD-10 Finland
Chronic nephritic syndrome, unspecified
+∞
28.5
27
*
B05DA
ATC
Isotonic solutions
84.7
28.2
31
*
L04AD02
ATC
tacrolimus; systemic (calcineurin inhibitors)
58.3
27.7
32
6
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
3.6
26.9
166
692
N06.8
ICD-10 Finland
Isolated proteinuria with specified morphological lesion, other
+∞
26.4
25
*
N06.2
ICD-10 Finland
Isolated proteinuria with specified morphological lesion, diffuse membranous glomerulonephritis
+∞
26.4
25
*
KA1AE
NOMESCO Finland
Kidney ultrasound examination
22.2
26.3
38
19
V03AE01
ATC
polystyrene sulfonate; oral
36.2
26.0
33
10
Z49.2
ICD-10 Finland
Other dialysis
101.0
26.0
28
*
B05DB
ATC
Hypertonic solutions
145.5
26.0
27
*
320
Kela drug reimbursment
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
267.9
25.0
25
*
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
7.4
23.8
59
93
M04AA01
ATC
allopurinol; systemic
4.4
22.2
90
254
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
4.5
21.1
81
216
KA2AE
NOMESCO Finland
Ultrasound examination transplanted kidney
116.8
20.8
22
*
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
7.7
20.6
49
72
N03.1
ICD-10 Finland
Chronic nephritic syndrome, focal and segmental glomerular lesions
+∞
20.0
19
*
JAK10
NOMESCO Finland
Laparotomy and insertion of peritoneal dialysis catheter
111.2
19.8
21
*
N06.3
ICD-10 Finland
Isolated proteinuria with specified morphological lesion, diffuse mesangial proliferative glomerulonephritis
+∞
18.9
18
*
N19
ICD-10 Finland
Unspecified kidney failure
10.4
18.4
36
38
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
6.2
18.2
51
94
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.7
18.0
195
1096
N03.2
ICD-10 Finland
Chronic nephritic syndrome, diffuse membranous glomerulonephritis
+∞
17.9
17
*
N03.8
ICD-10 Finland
Chronic nephritic syndrome, other
+∞
17.9
17
*
N04.2
ICD-10 Finland
Nephrotic syndrome, diffuse membranous glomerulonephritis
+∞
17.9
17
*
KA2AT
NOMESCO Finland
Biopsy of transplanted kidney with ultrasound guidance
188.9
17.7
18
*
N03.0
ICD-10 Finland
Chronic nephritic syndrome, minor glomerular abnormality
+∞
16.8
16
*
N25.8
ICD-10 Finland
Other disorders resulting from impaired renal tubular function
94.5
16.7
18
*
TJA35
NOMESCO Finland
Removal of peritoneal dialysis catheter
94.5
16.7
18
*
H02AB04
ATC
methylprednisolone; systemic
3.4
16.6
90
319
C10AA05
ATC
atorvastatin; oral
2.6
16.3
170
917
P01BA02
ATC
hydroxychloroquine; oral
4.5
16.2
60
152
B03XA01
ATC
erythropoietin; parenteral
49.9
16.2
19
*
C08CA13
ATC
lercanidipine; oral
3.6
15.9
78
255
N17.9
ICD-10 Finland
Acute renal failure, unspecified
9.6
15.8
32
36
WW200
NOMESCO Finland
Immunization
10.2
15.8
31
33
C08CA02
ATC
felodipine; oral
4.2
15.7
63
172
N08.39*E10.2
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic nephropathy
+∞
15.7
15
*
I10
ICD-10 Finland
Essential (primary) hypertension
2.5
15.7
237
1557
TK820
NOMESCO Finland
Peritoneal dialysis
89.0
15.7
17
*
V03AE02
ATC
sevelamer; oral
89.0
15.7
17
*
M05.8
ICD-10 Finland
Other seropositive rheumatoid arthritis
5.8
15.5
45
87
C02AC05
ATC
moxonidine; oral
6.1
14.9
41
74
N03.3
ICD-10 Finland
Chronic nephritic syndrome, diffuse mesangial proliferative glomerulonephritis
+∞
14.7
14
*
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
4.3
14.6
56
147
M06.0
ICD-10 Finland
Seronegative rheumatoid arthritis
8.6
14.4
31
39
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
5.5
13.4
40
80
C09CA01
ATC
losartan; oral
2.6
13.2
117
561
H02AB06
ATC
prednisolone; systemic
2.3
13.0
193
1208
C10AA01
ATC
simvastatin; oral
2.3
12.7
180
1095
RD210
NOMESCO Finland
NA
11.6
12.7
23
21
ZX120
NOMESCO Finland
Intravenous
3.9
12.7
55
161
K65.0
ICD-10 Finland
Acute peritonitis
18.1
12.6
19
11
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
5.8
12.6
36
68
N08.2
ICD-10 Finland
Glomerular disorders in blood diseases and disorders involving the immune mechanism
+∞
12.6
12
*
M06.9
ICD-10 Finland
Rheumatoid arthritis, unspecified
7.0
12.3
30
46
H05BX01
ATC
cinacalcet; oral
39.0
12.3
15
*
B03XA03
ATC
methoxy polyethylene glycol-epoetin beta; parenteral
39.0
12.3
15
*
WZB00
NOMESCO Finland
Telephone receipt or other advice
2.4
12.2
126
653
M10.9
ICD-10 Finland
Gout, unspecified
4.6
12.1
43
104
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
4.0
12.1
50
140
PG1DE
NOMESCO Finland
Other extensive ultrasound examination of artery
5.8
12.0
34
64
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
3.0
11.9
77
303
TNX10
NOMESCO Finland
Arthrocentesis, unspecified region, unspecified region
4.4
11.8
43
107
V03AE03
ATC
lanthanum carbonate; oral
67.2
11.7
13
*
L04AX01
ATC
azathioprine; systemic
5.8
11.7
33
62
N03.5
ICD-10 Finland
Chronic nephritic syndrome, diffuse mesangiocapillary glomerulonephritis
+∞
11.5
11
*
N08.39
ICD-10 Finland
Glomerular disorders in diabetes mellitus microalbuminuria
123.8
11.5
12
*
L01BA01
ATC
methotrexate; systemic (folic acid analog.)
5.6
11.4
33
64
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
17.8
11.3
17
10
E11.2
ICD-10 Finland
Type 2 diabetes mellitus, with renal complications
8.0
10.9
24
32
196
Kela drug reimbursment
Paricalcitol and cinacalcet
29.0
10.8
14
5
O12.1
ICD-10 Finland
Gestational proteinuria
113.2
10.5
11
*
C07AB07
ATC
bisoprolol; oral
2.1
10.2
180
1170
321
Kela drug reimbursment
Paricalcitol and cinacalcet
41.3
10.0
12
*
M01CB01
ATC
sodium aurothiomalate; parenteral
10.5
9.6
18
18
Z01.0
ICD-10 Finland
Examination of eyes and vision
2.6
9.6
76
334
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.3
9.6
102
524
TPX10
NOMESCO Finland
Implantation of vascular injection port
7.9
9.6
21
28
7910X
ICD-9 Finland
Nonspecific findings on examination of urine, Proteinuria[PROTEINURIA NUD]
102.6
9.5
10
*
WZC10
NOMESCO Finland
Extensive specialist consultion with written report
4.4
9.4
33
80
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
2.3
9.3
95
481
I12.0
ICD-10 Finland
Hypertensive renal disease with renal failure
14.2
9.3
15
11
E78.5
ICD-10 Finland
Hyperlipidaemia, unspecified
3.2
9.2
51
179
WX202
NOMESCO Finland
Supraclavicular plexus blockade
9.4
9.1
18
20
N18.5
ICD-10 Finland
Chronic kidney disease, stage 5
37.7
9.1
11
*
E11.8
ICD-10 Finland
Type 2 diabetes mellitus, with unspecified complications
3.2
9.0
48
165
OAB74
NOMESCO Finland
Nutritional guidance related to treatment and rehabilitation for medical condition
24.7
9.0
12
5
Z3231
NOMESCO Finland
Registered nurse
2.2
8.9
116
652
A07EC01
ATC
sulfasalazine; oral, rectal
3.3
8.8
44
145
TJA33
NOMESCO Finland
Percutaneous introduction of peritoneal dialysis catheter
51.3
8.7
10
*
J01FF01
ATC
clindamycin; systemic
2.2
8.7
109
601
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.1
8.7
111
620
J01MA02
ATC
ciprofloxacin; systemic
2.0
8.6
152
966
E10.2
ICD-10 Finland
Type 1 diabetes mellitus, With renal complications
28.3
8.5
11
*
L04AA13
ATC
leflunomide; oral
5.5
8.5
24
46
N04.5
ICD-10 Finland
Nephrotic syndrome, diffuse mesangiocapillary glomerulonephritis
+∞
8.4
8
*
D89.80
ICD-10 Finland
Immunoglobulin A (IgA) deposits in organisms
+∞
8.4
8
*
N06.4
ICD-10 Finland
Isolated proteinuria with specified morphological lesion, diffuse endocapillary proliferative glomerulonephritis
+∞
8.4
8
*
58209
ICD-8 Finland
Chronic nephritis, Unspecified
+∞
8.4
8
*
N05.9
ICD-10 Finland
Unspecified nephritic syndrome, unspecified
+∞
8.4
8
*
N06.5
ICD-10 Finland
Isolated proteinuria with specified morphological lesion, diffuse mesangiocapillary glomerulonephritis
+∞
8.4
8
*
L04AX03
ATC
methotrexate; systemic (immunosuppressants)
3.0
8.3
49
181
E78.01
ICD-10 Finland
Pure hypercholesterolaemia
2.3
8.0
81
404
C02CA01
ATC
prazosin; oral
8.1
8.0
17
22
N18
ICD-10 Finland
Chronic kidney disease
13.4
7.9
13
10
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
3.3
7.9
40
133
ZXD05
NOMESCO Finland
Urgent procedure
2.0
7.9
123
738
U14
ICPC
Kidney symptom/complaint
9.7
7.9
15
16
WX204
NOMESCO Finland
Axillary plexus blockaced
6.2
7.8
20
34
R06.0
ICD-10 Finland
Dyspnoea
2.1
7.8
98
537
J01MA14
ATC
moxifloxacin; systemic
3.1
7.7
43
151
M06.8
ICD-10 Finland
Other specified rheumatoid arthritis
18.8
7.6
11
6
D47.2
ICD-10 Finland
Monoclonal gammopathy of undetermined significance (MGUS)
12.2
7.6
13
11
XW000
NOMESCO Finland
Bone marrow biopsy
5.0
7.6
23
48
306
Kela drug reimbursment
Erythropoietin and darbepoetin
81.7
7.4
8
*
M13.9
ICD-10 Finland
Arthritis, unspecified
3.4
7.4
35
111
R50.9
ICD-10 Finland
Fever, unspecified
2.5
7.4
61
274
Z01.8
ICD-10 Finland
Other specified special examinations
2.2
7.4
83
435
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
3.4
7.3
35
112
N00.0
ICD-10 Finland
Acute nephritic syndrome, Minor glomerular abnormality
+∞
7.3
7
*
N04.3
ICD-10 Finland
Nephrotic syndrome, diffuse mesangial proliferative glomerulonephritis
+∞
7.3
7
*
N05.8
ICD-10 Finland
Unspecified nephritic syndrome, other
+∞
7.3
7
*
U88
ICPC
Glomerulonephritis/nephrosis
+∞
7.3
7
*
N06
ICD-10 Finland
Isolated proteinuria with specified morphological lesion
+∞
7.3
7
*
313
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)
5.0
7.3
22
46
WW500
NOMESCO Finland
Blood transfusion
4.4
7.3
25
60
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
2.3
7.3
72
355
C09CA06
ATC
candesartan; oral
2.2
7.2
84
445
M10.3
ICD-10 Finland
Gout due to impairment of renal function
30.7
7.2
9
*
RS221
NOMESCO Finland
NA
8.2
7.2
15
19
R4110
NOMESCO Finland
Physiotherapy
2.0
7.2
99
563
E66.8
ICD-10 Finland
Other obesity
4.0
7.1
27
71
XPX08
NOMESCO Finland
Intraoperative flow measurement
12.4
7.1
12
10
ZXE10
NOMESCO Finland
More than one and less than three hours
1.9
7.1
133
849
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
2.3
7.0
72
359
J01MA12
ATC
levofloxacin; systemic
2.2
6.9
78
407
C07AG02
ATC
carvedilol; oral
3.6
6.9
30
89
M05.9
ICD-10 Finland
Seropositive rheumatoid arthritis, unspecified
6.3
6.9
17
28
212
Kela drug reimbursment
Gout
7.4
6.8
15
21
ZXD30
NOMESCO Finland
Difficulties in perfomrming procedure
3.9
6.7
26
70
H26.3
ICD-10 Finland
Drug-induced cataract
23.0
6.7
9
*
SPAT1262
SPAT
Handing over of treatment supplies
2.2
6.7
76
398
281
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab
5.0
6.6
20
42
H02AB07
ATC
prednisone; oral
2.4
6.6
61
287
C08CA03
ATC
isradipine; systemic
12.6
6.6
11
9
XPX99
NOMESCO Finland
Other diagnostic examination of periferal vessel
3.2
6.6
33
110
RF420
NOMESCO Finland
NA
10.3
6.6
12
12
A10AB05
ATC
insulin aspart; parenteral (insulins and analog. for injection, fast-acting)
3.0
6.5
37
133
ZXE20
NOMESCO Finland
More than three and less than five hours
2.4
6.5
58
271
C10AA03
ATC
pravastatin; oral
3.3
6.5
31
100
ZXA05
NOMESCO Finland
Left side
2.0
6.5
99
584
A12AA12
ATC
[U] calcium acetate anhydrous; systemic
71.0
6.4
7
*
B25.8
ICD-10 Finland
Other cytomegaloviral diseases
71.0
6.4
7
*
KBV00
NOMESCO Finland
Insertion of stent into ureter
14.6
6.4
10
7
3AC01
NOMESCO Finland
NA
14.6
6.4
10
7
TPH04
NOMESCO Finland
Cathetrisation of vein
2.1
6.4
80
434
Z3229
NOMESCO Finland
Other healthcare associate professional
2.8
6.4
40
153
N02AX02
ATC
tramadol; systemic, rectal
1.8
6.3
156
1081
RF410
NOMESCO Finland
NA
11.3
6.3
11
10
WX002
NOMESCO Finland
Sedation and analgesia
2.1
6.3
72
377
N04.4
ICD-10 Finland
Nephrotic syndrome, diffuse endocapillary proliferative glomerulonephritis
+∞
6.3
6
*
5828A
ICD-9 Finland
Chronic glomerulonephritis, With other specified pathological lesion in kidney[GLOMERULONEPHRITIS CHRONICA ALIA DEF,EI NEFR SDR]
+∞
6.3
6
*
JN3AD
NOMESCO Finland
Abdominal CT examination
3.0
6.2
35
124
E66.00
ICD-10 Finland
Metabolic syndrome
3.2
6.2
31
104
B01AB05
ATC
enoxaparin; parenteral
1.9
6.1
112
704
A49.9
ICD-10 Finland
Bacterial infection, unspecified
2.5
6.1
46
198
M01AE01
ATC
ibuprofen; systemic, rectal
0.5
6.1
238
2807
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
5.7
6.1
16
29
ZY020
NOMESCO Finland
Telephone, letter or other consultation without direct patient contact
3.0
6.0
34
121
C10AA04
ATC
fluvastatin; oral
2.8
6.0
38
146
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3003458) Phosphate [Moles/volume] in Serum or Plasma
246
388
15.16
172.80
18.4
4.4
mmol/l
1.1
1.0
8.13
240
357
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
174
221
13.28
140.02
9.1
3.2
ng/l
153.0
74.1
7.38
162
196
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
116
88
18.25
128.52
5.6
2.1
mg/l
1.9
1.5
2.83
110
78
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
99
89
14.51
98.24
3.8
4.1
mg/l
45.5
27.2
1.89
74
71
(3034860) Kappa light chains.free [Mass/volume] in Serum
99
89
14.51
98.24
3.8
4.1
mg/l
68.9
109.4
0.24
73
71
(40760888) Immunoglobulin light chains.free panel - Serum
88
65
17.13
97.82
3.1
4.5
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
63
27
27.57
89.36
2.0
2.5
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
183
410
7.45
86.24
7.1
2.1
%
23.3
22.8
0.15
170
352
(3004789) Transferrin [Mass/volume] in Serum or Plasma
187
440
7.17
83.52
6.8
2.0
g/l
2.2
2.4
4.50
181
404
(3004588) Protein electrophoresis panel - Serum or Plasma
116
202
7.71
68.19
3.5
2.7
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
255
924
5.96
67.72
9.9
3.1
mg/l
645.8
113.8
2.29
239
592
(3009508) Creatinine [Moles/volume] in Urine
260
973
5.89
65.99
10.0
2.9
mmol/l
6.5
7.8
5.43
248
809
(3020682) Albumin/Creatinine [Ratio] in Urine
260
977
5.86
65.54
12.4
3.7
mg/mmol
74.3
7.5
19.97
242
609
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
61
47
15.17
65.42
8.8
2.0
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
214
685
5.64
65.32
7.3
2.5
e6/l
4.0
5.1
0.71
203
600
(3024561) Albumin [Mass/volume] in Serum or Plasma
302
1348
6.27
60.24
14.8
4.4
g/l
34.2
35.8
6.43
297
1268
(40768446) Kidney Pathology biopsy report
61
5
143.78
58.69
1.6
1.2
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
275
1174
5.42
56.76
10.3
3.1
—
—
—
0
0
(3012544) pH of Venous blood
125
285
5.95
55.14
9.2
3.2
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
248
1001
4.97
54.27
9.3
3.1
e6/l
21.9
124.9
0.95
229
775
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
86
142
7.46
52.31
9.3
2.7
mmol/l
23.3
24.3
1.83
79
130
(3030467) Casts [#/volume] in Urine by Automated count
232
909
4.76
52.27
8.5
3.0
e6/l
0.3
0.5
0.81
209
681
(3026493) Urate [Moles/volume] in Serum or Plasma
221
835
4.74
52.23
6.0
2.7
umol/l
385.7
6331.2
3.06
212
716
(3026782) Osmolality of Urine
189
638
4.76
51.67
7.5
2.8
mosm/kgh2o
502.5
565.1
4.27
176
543
(3002032) Base excess in Venous blood by calculation
120
280
5.72
51.29
10.4
3.2
mmol/l
1.1
2.1
1.80
98
223
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
55
57
11.05
48.57
8.4
6.9
iu/ml
283.3
246.0
—
9
12
(1616796) Gas panel - Central venous blood
55
60
10.49
46.79
8.0
2.7
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
303
1546
5.12
45.95
24.8
6.3
mmol/l
1.2
1.2
0.81
270
1312
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
80
141
6.86
45.46
2.5
2.3
g/l
1.6
1.6
0.08
74
125
(3018095) Leukocytes [#/volume] in Urine
254
1152
4.38
44.89
10.8
3.6
e6/l
76.4
96.1
0.16
234
826
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
266
1250
4.45
44.65
3.9
2.2
nmol/l
71.0
76.2
2.28
260
1105
(3018418) pH of Serum or Plasma
225
944
4.21
44.23
16.0
3.7
ph
7.4
7.4
2.16
64
179
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
71
115
7.31
43.63
4.2
2.6
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
71
115
7.31
43.63
4.2
2.6
g/l
3.9
3.7
0.61
59
82
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
71
115
7.31
43.63
4.2
2.6
g/l
7.7
7.5
0.38
60
86
(36304419) Bacteria [Presence] in Urine
215
881
4.16
43.54
8.2
3.0
—
—
—
0
0
(3018677) aPTT in Platelet poor plasma by Coagulation assay
153
496
4.40
42.85
2.5
2.0
s
29.6
29.8
0.09
153
482
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
37
25
16.23
42.19
1.0
1.1
u/ml
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
85
185
5.58
38.52
7.1
3.4
mmol/l
0.8
1.7
1.49
66
140
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
64
106
7.01
38.35
4.5
2.7
g/l
3.0
3.2
0.77
59
82
(3000991) Gas panel - Venous blood
101
256
4.96
38.35
11.6
7.8
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
227
1034
3.81
37.95
9.2
5.5
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
274
1426
4.01
37.14
10.9
5.7
%
0.7
0.7
0.72
264
1334
(3012095) Magnesium [Moles/volume] in Serum or Plasma
144
491
4.04
36.86
4.6
3.2
mmol/l
0.8
0.8
0.02
138
467
(3009343) pH of Capillary blood
86
197
5.30
36.69
7.4
3.3
ph
7.4
7.4
0.78
28
21
(3006504) Eosinophils/100 leukocytes in Blood
277
1467
3.97
36.22
10.9
5.7
%
3.0
2.7
0.90
268
1371
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
86
200
5.22
36.02
7.4
3.3
kpa
5.0
5.1
0.30
86
187
(3019069) Monocytes/100 leukocytes in Blood
277
1476
3.93
35.68
11.1
6.0
%
8.5
8.6
0.23
267
1391
(3018010) Neutrophils/100 leukocytes in Blood
277
1490
3.88
34.84
10.7
5.6
%
59.5
57.5
1.86
266
1405
(3047189) Immunofixation for 24 hour Urine
27
14
20.63
34.75
1.9
1.4
—
—
—
0
0
(3028626) Oxygen [Partial pressure] in Capillary blood
49
67
8.21
34.72
5.0
2.3
kpa
8.7
8.1
1.39
49
61
(3006315) Basophils [#/volume] in Blood
285
1565
3.95
34.66
10.6
5.7
e9/l
0.0
0.0
1.82
266
1369
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
55
86
7.27
34.66
4.6
3.0
g/l
0.0
0.1
0.17
55
81
(3015235) Bicarbonate [Moles/volume] in Capillary blood
54
83
7.38
34.56
4.8
2.3
mmol/l
23.7
24.7
0.77
54
73
(3001604) Monocytes [#/volume] in Blood
284
1560
3.92
34.42
10.6
5.7
e9/l
0.6
0.6
1.19
265
1361
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
46
59
8.69
34.34
3.3
1.2
u/ml
137.9
105.3
—
9
13
(3002030) Lymphocytes/100 leukocytes in Blood
277
1512
3.79
33.56
11.2
5.9
%
25.3
27.5
2.43
268
1419
(3021901) Oxygen saturation in Capillary blood
44
56
8.72
33.03
5.1
2.2
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
288
1622
3.86
33.01
11.0
5.9
e9/l
0.2
0.2
0.78
268
1440
(3017143) Hepatitis C virus Ab [Presence] in Serum
119
380
4.05
33.00
3.1
1.5
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
96
263
4.50
32.71
5.0
2.8
e9/l
73.2
71.7
0.15
73
202
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
51
81
7.08
31.60
4.6
3.1
g/l
0.0
0.0
0.49
51
76
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
46
66
7.76
31.21
3.2
1.3
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
282
1600
3.67
31.19
11.0
5.7
e9/l
2.4
1.9
0.42
266
1434
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
58
107
6.18
31.07
1.5
1.6
titre
288.0
192.0
—
5
5
(3037121) Protein [Mass/volume] in Urine
57
106
6.12
30.26
6.8
3.4
g/l
1.0
0.2
2.55
44
38
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
24
13
19.59
30.21
2.6
2.0
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
45
68
7.34
29.12
3.4
1.3
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
32
32
10.79
28.64
1.1
1.3
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
42
60
7.71
28.55
1.7
1.8
—
—
—
0
0
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
40
54
8.13
28.53
1.2
1.3
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
32
35
9.86
26.85
2.2
2.5
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
265
1537
3.20
26.39
10.4
5.0
estimate
0.0
0.0
0.00
90
290
(3013650) Neutrophils [#/volume] in Blood by Automated count
297
1841
3.47
26.37
14.0
9.1
e9/l
4.4
4.1
1.68
279
1614
(3037467) Urinalysis macro (dipstick) panel - Urine
330
2190
4.08
26.16
11.9
4.1
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
127
487
3.37
26.03
3.0
1.5
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
265
1558
3.13
25.35
8.0
3.6
estimate
0.0
0.0
0.49
85
275
(3035350) Ketones [Presence] in Urine by Test strip
262
1532
3.11
25.28
8.0
3.6
estimate
0.0
0.0
0.00
88
289
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
85
256
3.96
25.06
7.2
2.7
ml/min/173m2
41.7
66.9
7.32
57
108
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
133
536
3.23
24.98
6.0
2.9
e6/l
1.4
2.0
0.72
96
294
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
41
66
6.82
24.96
1.7
1.2
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
136
565
3.15
24.14
5.4
2.7
e6/l
0.6
1.0
2.40
99
320
(3037522) Nuclear Ab [Titer] in Serum
115
436
3.31
23.77
1.4
1.4
titre
601.8
522.9
0.13
22
97
(40767503) Oxygen content in Capillary blood by calculation
38
60
6.90
23.53
5.4
2.3
%
16.3
16.5
0.07
33
27
(3004775) Volume in Urine collected for unspecified duration
24
21
12.10
23.33
2.7
2.0
ml
789.6
396.5
2.93
18
11
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
39
64
6.65
23.29
1.8
1.2
u/ml
235.2
264.4
0.21
26
39
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
45
86
5.78
23.07
3.4
3.2
u/ml
0.3
0.4
0.64
24
48
(3001122) Ferritin [Mass/volume] in Serum or Plasma
235
1342
2.85
22.83
7.1
2.6
ug/l
214.6
132.4
3.64
228
1231
(3032080) INR in Blood by Coagulation assay
229
1296
2.83
22.54
13.4
8.8
inr
1.2
1.2
0.44
93
390
(3023368) Bacteria identified in Blood by Culture
176
879
2.81
21.93
6.2
4.1
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
46
99
5.13
20.66
1.6
1.2
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
72
225
3.69
19.88
2.0
1.5
g/l
1.6
1.5
0.08
65
207
(3021440) Promyelocytes/100 leukocytes in Blood
74
237
3.61
19.68
7.0
4.9
%
0.1
0.2
0.45
30
75
(3024928) Oxygen saturation in Venous blood
38
72
5.73
19.60
5.5
2.1
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
233
1396
2.63
19.45
22.4
9.5
e9/l
0.0
0.0
0.27
207
1146
(3042936) Bacteria identified in Isolate by Culture
111
465
2.93
18.83
2.6
1.9
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
87
317
3.24
18.82
4.3
3.2
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
33
57
6.23
18.69
1.1
1.5
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
71
229
3.56
18.64
6.7
4.9
%
0.1
0.1
0.27
29
67
(3002179) Metamyelocytes/100 leukocytes in Blood
71
230
3.54
18.51
6.2
4.7
%
0.5
0.4
0.28
24
60
(3017181) Myelocytes/100 leukocytes in Blood
75
254
3.41
18.23
6.9
4.8
%
0.9
0.9
0.00
31
84
(3026008) Bacteria identified in Urine by Culture
173
921
2.56
18.18
4.0
3.1
—
—
—
0
0
(3012501) Base excess in Blood by calculation
34
63
5.81
17.93
8.8
2.9
mmol/l
2.2
2.3
0.09
22
43
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
23
28
8.66
17.68
1.4
1.2
—
—
—
0
0
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
22
26
8.90
17.29
1.1
1.2
u/l
112.5
49.7
0.67
17
17
(46235355) HIV 1 and 2 tests - Meaningful Use set
122
560
2.71
17.22
3.2
1.7
—
—
—
0
0
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
16
0
+∞
16.78
6.4
0.0
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
68
228
3.39
16.73
1.8
1.6
—
—
—
0
0
(3048402) Erythrocytes [#/area] in Urine sediment by Automated count
17
16
11.06
15.64
1.6
1.5
u/field
3.8
0.8
—
11
9
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
112
530
2.55
14.56
2.1
1.8
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
18
5
37.60
14.56
1.0
1.0
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
251
1691
2.33
14.38
7.6
6.3
umol/l
11.4
11.2
0.06
245
1614
(3031040) Bacteria [#/volume] in Urine by Automated count
293
2117
2.49
14.19
8.3
4.3
e6/l
327.3
258.8
—
7
33
(3041096) Erythrocytes [Presence] in Urine by Automated
154
850
2.33
14.18
7.6
3.3
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
22
34
6.79
13.79
1.4
1.2
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
25
45
5.86
13.53
1.2
1.3
—
—
—
0
0
(3017704) Immunofixation for Urine
16
17
9.77
13.52
1.6
1.8
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
18
7
26.83
13.48
1.0
1.0
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
141
775
2.27
12.88
3.0
2.0
mg/l
3.0
3.1
0.22
128
660
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
34
85
4.28
12.65
1.9
1.4
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
268
1917
2.24
12.44
10.1
4.5
mmol/l
6.9
6.7
0.93
258
1782
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
22
38
6.07
12.40
1.3
1.1
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
165
980
2.17
12.34
2.8
2.1
u/l
143.6
217.3
1.65
159
921
(3029937) Albumin [Presence] in Urine by Test strip
146
842
2.16
11.62
9.0
3.8
estimate
0.1
0.0
1.22
64
285
(3022313) Gas panel - Capillary blood
45
147
3.33
11.42
8.4
3.3
—
—
—
0
0
(40758558) Short blood count panel - Blood
142
816
2.16
11.36
10.1
6.7
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
168
1036
2.08
11.11
3.6
2.4
u/l
63.6
56.7
1.80
162
970
(3052851) Hemolysis interference index of Serum or Plasma
33
89
3.95
11.10
4.5
3.2
—
—
—
0
0
(3024471) HLA-A [Type]
15
7
22.20
10.76
1.0
1.0
—
—
—
0
0
(3024932) HLA-DR beta [Type]
15
7
22.20
10.76
1.0
1.1
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
168
1046
2.05
10.74
6.8
3.2
mmol/l
2.3
2.4
1.97
159
913
(3045414) Leukocytes [Presence] in Urine
41
132
3.35
10.64
2.8
1.7
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
185
1198
2.02
10.56
8.6
3.8
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
40
129
3.34
10.35
3.1
2.8
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
126
716
2.12
10.20
8.1
5.0
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
63
265
2.64
10.18
10.3
3.4
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
79
371
2.41
10.13
2.0
1.9
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
31
86
3.83
10.03
1.5
1.8
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
31
87
3.78
9.86
3.8
2.2
ug/min
407.8
81.5
1.84
22
53
(3021879) Hepatitis B virus core Ab [Presence] in Serum
58
240
2.66
9.66
2.4
1.4
—
—
—
0
0
(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture
9
0
+∞
9.41
4.1
0.0
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
34
105
3.45
9.40
2.7
1.2
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
77
369
2.35
9.39
1.9
1.8
—
—
—
0
0
(3030981) Hyaline casts [#/volume] in Urine by Automated count
48
185
2.82
9.15
8.5
2.6
e6/l
0.1
0.2
0.18
48
177
(3013707) Erythrocyte sedimentation rate by Westergren method
301
2385
2.10
9.02
8.2
4.0
mm/h
20.4
12.0
10.40
292
2190
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
34
109
3.32
8.88
2.6
2.2
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
160
1035
1.92
8.73
3.5
2.3
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
121
715
2.00
8.59
7.1
3.6
—
—
—
0
0
(4035726)
62
281
2.43
8.53
1.6
1.4
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
105
592
2.05
8.48
2.3
1.8
nmol/l
1294.3
1182.5
0.46
91
452
(3021960) Folate [Moles/volume] in Serum or Plasma
126
759
1.97
8.45
1.9
1.5
nmol/l
21.4
21.2
0.03
120
650
(3040661) Urea [Moles/volume] in Peritoneal dialysis fluid
8
0
+∞
8.36
4.5
0.0
mmol/l
16.1
—
—
8
0
(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid
8
0
+∞
8.36
4.5
0.0
umol/l
349.9
—
—
8
0
(3033926) Protein [Mass/volume] in Peritoneal dialysis fluid
8
0
+∞
8.36
3.3
0.0
g/l
1.3
—
—
8
0
(3007164) IgA [Mass/volume] in Serum or Plasma
113
659
2.00
8.29
1.9
1.4
g/l
2.9
2.5
0.76
83
410
(40761535) Cells panel - Urine sediment
58
259
2.45
8.23
9.9
3.4
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
74
374
2.20
7.89
2.5
1.6
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
183
1271
1.82
7.74
2.4
2.0
pmol/l
103.1
93.2
2.36
109
677
(3027801) Oxygen [Partial pressure] in Arterial blood
72
365
2.19
7.61
6.4
7.1
kpa
10.8
12.0
1.40
67
349
(3011648) Oxygen content in Venous blood
14
26
5.55
7.30
5.4
1.8
%
10.5
10.8
0.10
14
26
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
17
38
4.63
7.25
3.6
2.0
pg
33.9
33.2
0.47
17
38
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
20
52
4.00
7.07
1.3
1.5
—
—
—
0
0
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
12
20
6.16
6.94
1.6
1.5
u/l
27.8
5.5
—
6
8
(3003396) Base excess in Arterial blood by calculation
70
366
2.11
6.81
6.5
7.2
mmol/l
0.6
1.2
0.63
55
285
(3019230) Fractional oxyhemoglobin in Venous blood
21
59
3.70
6.68
6.0
1.6
%
78.3
60.3
3.44
21
59
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
28
95
3.10
6.68
1.4
1.3
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
22
64
3.58
6.66
1.3
1.7
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
26
85
3.20
6.59
1.3
1.6
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
26
85
3.20
6.59
1.4
1.6
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
14
29
4.97
6.50
1.1
1.2
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
204
1514
1.72
6.49
4.9
4.1
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
121
774
1.81
6.48
3.3
2.3
—
—
—
0
0
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
28
97
3.03
6.46
1.9
2.3
ug/l
645.1
229.9
0.52
28
91
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
44
194
2.43
6.40
1.4
1.4
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
16
38
4.35
6.34
1.2
1.5
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
35
139
2.67
6.31
1.8
2.3
u/l
35.6
39.1
0.48
30
126
(3045424) Erythrocytes [Presence] in Urine
19
52
3.79
6.27
2.0
1.6
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
16
39
4.23
6.14
1.1
1.2
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
174
1250
1.70
6.13
5.4
3.7
ng/l
43.9
41.3
0.14
145
890
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
38
160
2.52
6.09
7.0
9.5
—
—
—
0
0
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
12
24
5.13
5.78
1.9
2.5
u/field
0.7
3.0
—
6
7
(3022806) Fractional oxyhemoglobin in Capillary blood
16
41
4.02
5.77
3.0
2.1
%
89.7
90.4
0.16
16
41
(3007566) Smooth muscle Ab [Titer] in Serum
26
94
2.89
5.58
1.2
1.2
—
75.0
—
0
6
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
126
849
1.71
5.51
1.9
1.7
mmol/l
1.7
1.4
0.72
111
702
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
345
3044
2.05
5.45
6.2
4.0
mmol/l
1.6
1.3
2.65
333
2795
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
137
948
1.68
5.41
4.3
3.1
ng/l
4823.0
1134.9
3.46
127
806
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
8
299
0.25
5.35
1.0
1.7
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
10
18
5.67
5.35
2.5
5.3
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
24
85
2.94
5.35
1.8
1.2
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
11
22
5.11
5.29
1.3
1.4
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
17
49
3.58
5.23
1.4
1.2
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
357
3212
2.16
5.00
37.6
14.0
mg/l
18.4
23.5
3.16
321
2521
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
335
2951
1.89
4.96
9.7
5.8
mmol/mol
40.6
39.9
0.66
325
2751
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
36
164
2.31
4.89
6.1
9.5
mmol/l
24.2
24.6
0.39
36
152
(3022217) INR in Platelet poor plasma by Coagulation assay
68
395
1.87
4.86
24.5
19.5
inr
1.2
1.3
—
10
52
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
19
62
3.17
4.86
1.9
1.2
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
149
1077
1.62
4.85
4.0
3.2
u/l
51.3
31.9
0.58
139
1029
(3019060) Gas panel - Arterial blood
42
206
2.16
4.79
5.5
4.1
—
—
—
0
0
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
12
29
4.24
4.66
1.2
1.2
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
19
64
3.07
4.62
1.3
1.7
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
349
3135
1.97
4.59
6.9
4.4
mmol/l
1.4
1.4
1.15
339
2887
(3000330) Specific gravity of Urine by Test strip
34
158
2.26
4.42
7.7
4.1
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
14
40
3.59
4.37
1.1
1.2
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
26
108
2.51
4.32
3.2
2.8
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
37
180
2.16
4.32
1.3
1.3
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
349
3150
1.93
4.30
7.0
4.5
mmol/l
4.5
4.6
0.97
339
2920
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
7
6
11.84
4.29
1.0
1.2
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
19
67
2.93
4.28
1.6
1.5
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
19
67
2.93
4.28
1.6
1.5
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
12
32
3.84
4.11
1.5
1.4
nmol/l
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
12
32
3.84
4.11
1.3
1.2
—
—
—
0
0
(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay
10
24
4.25
3.91
1.0
1.2
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
64
390
1.76
3.90
2.0
2.2
ug/g
178.4
120.1
0.52
56
311
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
90
603
1.64
3.87
6.2
3.5
ng/l
103.4
207.7
0.94
75
468
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
352
3211
1.88
3.82
7.3
5.0
mmol/l
2.6
2.7
3.61
343
2954
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
12
34
3.61
3.79
1.1
1.4
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
50
287
1.85
3.70
2.5
1.6
—
—
—
0
0
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
27
123
2.28
3.70
7.3
4.5
%
1.7
1.5
0.57
27
113
(3051611) Lipemic interference index of Serum or Plasma
11
30
3.74
3.66
4.5
3.0
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
337
3046
1.72
3.63
36.6
13.0
ml/min/173m2
61.9
81.5
21.75
311
2517
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
37
193
2.01
3.62
2.0
1.7
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
18
68
2.73
3.61
3.5
1.8
—
—
—
0
0
(3044889) 12 lead EKG panel
264
2260
1.51
3.57
4.9
3.9
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
14
46
3.12
3.56
1.1
1.8
—
—
—
0
0
(3004809) Band form neutrophils/100 leukocytes in Blood
14
46
3.12
3.56
4.0
3.9
%
4.1
1.0
0.54
14
40
(3022621) pH of Urine by Test strip
39
209
1.96
3.55
3.8
2.5
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
13
41
3.24
3.52
1.2
1.3
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
12
36
3.41
3.50
1.3
1.2
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
275
2383
1.51
3.43
4.2
3.8
pmol/l
14.8
14.8
0.05
258
2154
(3003694) ABO and Rh group [Type] in Blood
119
874
1.52
3.41
1.6
1.4
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
95
665
1.56
3.38
1.8
1.7
pmol/l
465.7
437.4
0.37
84
549
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
8
14
5.81
3.35
3.0
2.4
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
9
19
4.82
3.25
4.8
3.1
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
99
706
1.54
3.23
1.4
1.2
u/ml
2.3
1.7
0.28
35
189
(3019225) pH of Specimen
50
300
1.76
3.22
18.5
3.9
—
—
—
0
0
(4062490)
10
28
3.64
3.21
3.0
1.4
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
7
11
6.45
3.19
1.9
1.0
miu/ml
1470.3
1418.8
—
7
11
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
15
56
2.74
3.09
1.1
1.0
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
30
154
2.03
3.09
2.4
2.4
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
6
8
7.59
3.06
2.0
1.1
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
6
8
7.59
3.06
1.2
1.4
—
—
—
0
0
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
22
100
2.27
3.05
2.0
2.6
%
85.8
89.2
0.22
22
95
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
9
21
4.36
3.01
1.3
1.0
—
—
—
0
0
(3036048) Francisella tularensis Ab [Titer] in Serum
5
5
10.10
2.98
1.0
1.0
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
60
387
1.65
2.98
3.3
2.8
umol/l
7.4
7.8
0.13
53
342
(3007930) Methemoglobin/Hemoglobin.total in Blood
25
122
2.12
2.94
7.7
4.7
%
0.9
0.9
0.04
25
113
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
22
102
2.23
2.92
1.9
1.5
iu/ml
2.1
0.0
—
5
21
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
10
30
3.39
2.92
1.3
1.4
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
363
3399
1.84
2.82
23.7
10.5
u/l
25.6
26.7
0.36
358
3284
(3023419) Bacteria identified in Sputum by Culture
12
42
2.92
2.77
1.4
2.8
—
—
—
0
0
(3002256) Pathology report gross observation
58
379
1.62
2.74
1.3
1.3
—
—
—
0
0
(3013727) Leukocytes other/100 leukocytes in Blood
6
10
6.07
2.70
4.2
5.1
%
57.5
51.9
—
6
10
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
8
19
4.27
2.69
2.0
1.8
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
8
19
4.27
2.69
2.0
1.8
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
12
43
2.85
2.67
1.2
1.8
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
12
43
2.85
2.67
2.9
3.9
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
12
43
2.85
2.67
1.4
1.7
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
10
32
3.18
2.66
1.4
1.2
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
13
49
2.71
2.65
1.5
1.6
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
7
194
0.35
2.62
1.1
1.4
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
7
15
4.73
2.61
1.0
2.3
u/ml
1108.0
670.9
—
7
15
(3006922) Hepatitis E virus Ab [Presence] in Serum
8
20
4.06
2.58
1.1
1.1
—
—
—
0
0
(3052592) Norovirus Ag [Presence] in Stool
5
7
7.22
2.55
1.8
1.3
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
9
26
3.52
2.49
5.3
2.2
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
15
63
2.44
2.49
1.1
1.1
—
—
—
0
0
(40768443) Skin Pathology biopsy report
27
145
1.93
2.48
1.1
1.2
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
14
57
2.51
2.47
1.4
1.6
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
10
34
2.99
2.43
1.2
1.6
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
18
84
2.20
2.38
1.2
1.2
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
5
8
6.31
2.38
1.0
1.0
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
7
17
4.17
2.37
1.1
1.0
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
7
17
4.17
2.37
1.1
1.0
—
—
—
0
0
(3024263) Appearance of Synovial fluid
7
17
4.17
2.37
4.3
1.5
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
6
13
4.67
2.28
1.0
1.0
—
—
—
0
0
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
5
9
5.61
2.22
1.2
4.0
%
156.0
100.8
—
5
9
(40765096) Chromosome analysis panel by Banding
5
9
5.61
2.22
1.2
1.0
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
315
2903
1.42
2.09
5.2
4.5
mu/l
1.9
2.3
0.50
303
2643
(3021788) Differential panel - Synovial fluid
11
44
2.54
2.03
2.5
1.5
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
11
44
2.54
2.03
1.5
1.6
—
—
—
0
0
(21494434) Karyotype in Bone marrow
10
38
2.67
2.02
1.0
1.1
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
55
382
1.51
2.02
1.7
1.4
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
95
733
1.39
2.01
2.1
1.8
mg/l
1.9
1.2
0.56
77
569
(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
5
11
4.59
1.94
1.8
2.6
%
121.6
101.0
—
5
11
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
5
11
4.59
1.94
3.0
7.3
—
—
—
0
0
(3022145) Colonoscopy Study observation
53
369
1.50
1.93
1.4
1.3
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
16
301
0.51
1.91
1.2
1.4
—
—
—
0
0
(3041354) Potassium [Moles/volume] in Venous blood
12
52
2.35
1.89
2.5
2.9
mmol/l
3.9
4.0
0.46
12
52
(3033705) Calcium.ionized [Moles/volume] in Venous blood
12
52
2.35
1.89
2.5
2.9
—
—
—
0
0
(3035285) Chloride [Moles/volume] in Venous blood
12
52
2.35
1.89
2.5
2.9
mmol/l
103.2
105.7
0.80
12
52
(44790048)
11
46
2.43
1.87
1.5
1.6
—
—
—
0
0
(44790049)
11
46
2.43
1.87
1.5
1.6
—
—
—
0
0
(44790047)
11
46
2.43
1.87
1.5
1.6
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
11
46
2.43
1.87
2.1
2.9
—
—
—
0
0
(44806118)
11
46
2.43
1.87
1.5
1.6
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
23
131
1.80
1.82
2.4
1.8
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
13
60
2.21
1.79
5.6
3.5
%
61.0
57.9
0.41
13
60
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
8
30
2.70
1.73
1.0
1.0
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
7
24
2.95
1.73
1.1
1.0
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
17
90
1.93
1.68
6.7
5.4
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
21
120
1.79
1.65
2.3
1.7
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
15
77
1.99
1.61
1.2
1.2
—
—
—
0
0
(4024509)
7
26
2.72
1.58
1.3
1.3
—
—
—
0
0
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
21
122
1.76
1.58
1.2
1.1
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
5
15
3.36
1.53
1.0
1.5
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
5
15
3.36
1.53
1.0
1.9
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
5
15
3.36
1.53
1.0
1.9
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
5
15
3.36
1.53
1.4
1.2
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
5
15
3.36
1.53
1.0
1.9
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
15
79
1.93
1.51
1.5
1.3
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
26
399
0.63
1.51
16.0
7.3
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
12
58
2.10
1.50
5.5
3.2
e9/l
4.2
4.4
0.10
12
58
(40761511) CBC panel - Blood by Automated count
352
3357
1.45
1.49
34.8
12.9
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
9
37
2.47
1.49
1.1
1.8
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
9
37
2.47
1.49
1.1
1.8
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
9
37
2.47
1.49
1.1
1.8
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
16
87
1.87
1.48
2.6
2.2
u/l
4091.2
4282.0
—
5
29
(3013512) EKG study
113
935
1.29
1.47
5.6
3.9
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
5
17
2.96
1.36
1.4
1.2
—
—
—
0
0
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
5
17
2.96
1.36
1.4
1.2
—
1.1
—
0
5
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
0
40
0.00
1.33
0.0
1.5
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
14
76
1.87
1.31
1.3
1.3
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
5
18
2.80
1.29
1.0
1.8
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
5
18
2.80
1.29
1.0
1.8
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
5
18
2.80
1.29
1.0
1.8
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
5
18
2.80
1.29
1.0
1.8
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
34
238
1.47
1.25
1.3
1.2
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
8
36
2.25
1.25
4.4
3.6
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
31
438
0.68
1.23
1.5
1.4
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
5
19
2.65
1.22
2.0
1.4
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
5
19
2.65
1.22
2.0
1.4
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
6
26
2.33
1.19
2.2
1.6
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
17
103
1.68
1.14
1.2
1.5
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
145
1274
1.22
1.09
2.2
2.0
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
7
32
2.21
1.08
1.1
1.6
—
—
—
0
0
(3017354) Segmented neutrophils/100 leukocytes in Blood
7
33
2.14
1.06
3.0
3.1
%
59.9
54.3
—
7
25
(3009542) Hematocrit [Volume Fraction] of Blood
306
2898
1.25
1.06
32.6
15.0
%
37.8
40.2
4.57
211
2126
(3044242) Glucose [Moles/volume] in Arterial blood
5
22
2.29
1.03
2.4
4.5
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
5
23
2.19
0.98
4.8
3.6
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
5
23
2.19
0.98
1.6
1.0
—
—
—
0
0
(3026361) Erythrocytes [#/volume] in Blood
366
3554
1.41
0.98
52.1
20.6
e12/l
4.3
4.5
8.99
361
3467
(3001019) Free T4 and TSH panel - Serum or Plasma
8
144
0.55
0.95
2.0
1.8
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
6
28
2.16
0.92
1.2
1.1
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
8
43
1.88
0.88
1.1
1.6
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
13
80
1.65
0.85
1.2
1.1
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
6
31
1.95
0.84
1.0
1.2
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
55
448
1.26
0.83
1.2
1.2
—
—
—
0
0
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
10
58
1.74
0.80
1.1
1.1
u/l
19.0
17.5
—
10
50
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
6
33
1.83
0.79
1.0
1.2
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
6
33
1.83
0.79
1.3
1.5
—
—
—
0
0
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
6
33
1.83
0.79
1.0
1.1
—
—
—
0
0
(3000492) Spirometry study
40
315
1.30
0.79
1.4
1.5
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
5
25
2.01
0.73
4.0
1.7
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
5
26
1.93
0.71
1.4
1.9
—
—
—
0
0
(3019897) Erythrocyte distribution width [Ratio] by Automated count
5
26
1.93
0.71
1.4
2.4
%
12.8
13.1
—
5
26
(3011288) Drugs identified in Urine by Screen method
10
61
1.66
0.69
1.7
1.6
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
45
368
1.25
0.68
1.7
1.7
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
7
43
1.64
0.67
1.6
1.1
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
7
43
1.64
0.67
1.6
1.1
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
5
28
1.80
0.66
1.2
1.2
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
78
679
1.19
0.64
9.1
4.0
kg/l
1.0
1.0
0.44
13
89
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
5
29
1.73
0.64
1.4
1.4
—
—
—
0
0
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
8
50
1.61
0.61
1.3
2.5
u/ml
3.1
85.1
—
8
45
(1617658) Protocol used for examination of sentinel lymph nodes
0
21
0.00
0.60
0.0
1.0
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
8
52
1.55
0.60
2.9
1.8
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
5
86
0.58
0.57
1.4
1.4
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
15
107
1.42
0.56
1.3
1.2
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
15
107
1.42
0.56
1.3
1.2
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
15
108
1.40
0.54
1.3
1.2
—
—
—
0
0
(4268621)
6
39
1.55
0.53
2.3
2.3
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
10
146
0.68
0.53
3.2
1.5
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
132
1218
1.13
0.50
4.1
5.0
ug/l
2.3
2.6
0.28
120
1102
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
7
46
1.53
0.48
1.1
1.1
—
—
—
0
0
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
7
48
1.47
0.47
1.4
1.2
mmol/l
7.4
7.5
—
7
30
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
17
129
1.33
0.46
1.5
1.7
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
16
209
0.76
0.46
1.1
1.2
iu/ml
25.2
160.1
—
6
84
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
5
83
0.60
0.46
1.8
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
5
84
0.59
0.46
1.8
1.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
5
84
0.59
0.46
1.8
1.4
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
21
165
1.29
0.46
1.5
1.8
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
62
547
1.16
0.45
1.2
1.3
iu/ml
101.3
34.0
0.72
20
177
(3020891) Body temperature
17
130
1.32
0.44
8.2
4.5
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
6
93
0.64
0.42
2.2
1.4
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
0
15
0.00
0.41
0.0
1.1
—
8.5
—
0
15
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
0
15
0.00
0.41
0.0
1.0
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
5
35
1.43
0.39
1.0
1.1
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
5
35
1.43
0.39
1.4
1.1
titre
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
5
35
1.43
0.39
1.0
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
5
35
1.43
0.39
1.0
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
5
36
1.39
0.38
1.0
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
5
36
1.39
0.38
1.0
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
5
36
1.39
0.38
1.0
1.1
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
5
36
1.39
0.38
1.8
1.1
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
226
2171
1.10
0.38
5.0
3.2
u/l
70.4
49.9
1.33
212
2039
(40768806) Pleura Pathology biopsy report
5
37
1.36
0.37
1.0
1.8
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
25
208
1.22
0.36
1.1
1.3
—
38.6
—
0
12
(3047007) Chlamydophila sp Ab [Presence] in Serum
6
41
1.47
0.36
1.0
1.1
—
—
—
0
0
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
6
44
1.37
0.34
1.2
1.1
—
11.9
—
0
5
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
6
44
1.37
0.34
1.0
1.0
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
27
228
1.20
0.34
1.9
2.4
—
18.1
—
0
10
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
207
1987
1.09
0.34
3.1
3.0
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
10
75
1.34
0.30
1.4
1.3
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
58
527
1.12
0.30
1.2
1.3
u/ml
46.7
13.2
0.54
15
203
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
8
63
1.28
0.28
1.5
1.3
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
25
289
0.86
0.27
1.3
1.4
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
8
66
1.22
0.27
1.5
1.8
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
59
542
1.10
0.26
1.5
1.5
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
43
388
1.12
0.25
2.2
1.8
%
1.7
1.5
0.84
37
342
(3003338) MCHC [Mass/volume]
274
2684
1.07
0.22
42.6
18.3
g/l
330.0
332.8
5.51
274
2670
(3025130) Human papilloma virus identified in Specimen
5
41
1.22
0.22
1.8
1.8
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
0
11
0.00
0.21
0.0
1.6
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
2.1
—
17.5
—
0
10
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
63
587
1.09
0.21
2.9
2.9
mmol/l
2.5
2.4
1.61
55
524
(3004716) Salmonella sp identified in Stool by Organism specific culture
20
173
1.16
0.21
1.3
1.3
—
—
—
0
0
(3009613) Erythrocytes [#/volume] in Peritoneal fluid
0
12
0.00
0.21
0.0
1.3
—
5543.4
—
0
5
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
11
89
1.24
0.21
1.3
1.8
pmol/l
136.7
230.0
3.05
11
82
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
0
14
0.00
0.20
0.0
4.0
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
9
111
0.81
0.20
1.7
1.8
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
6
52
1.16
0.19
1.0
1.2
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
10
121
0.82
0.18
1.5
1.6
—
—
—
0
0
(4010399)
27
243
1.12
0.17
1.4
1.4
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
6
80
0.75
0.15
1.2
1.1
—
—
—
0
0
(1002224) Polysomnography panel
12
139
0.86
0.14
1.2
1.1
—
—
—
0
0
(4094501)
10
84
1.20
0.14
1.1
1.1
—
—
—
0
0
(3009466) Valproate [Moles/volume] in Serum or Plasma
5
45
1.11
0.10
1.2
4.6
umol/l
269.2
357.1
—
5
40
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
5
45
1.11
0.10
3.4
3.0
nmol/l
6.2
3.9
—
5
45
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
5
46
1.09
0.09
1.8
1.4
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
5
47
1.06
0.09
1.8
1.4
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
5
47
1.06
0.09
1.8
1.4
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
5
47
1.06
0.09
1.8
1.4
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
5
47
1.06
0.09
1.8
1.4
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
5
48
1.04
0.09
1.8
1.4
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
112
1144
0.97
0.07
4.8
2.8
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
10
89
1.13
0.07
1.1
1.1
—
12.1
—
0
10
(3016879) Cocaine [Presence] in Urine
10
89
1.13
0.07
1.3
1.4
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
16
173
0.92
0.07
1.0
1.0
—
—
—
0
0
(4034850)
8
94
0.85
0.06
15.3
10.2
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
32
333
0.96
0.05
3.4
4.0
ug/l
3.5
45.2
1.07
23
278
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
97
986
0.98
0.04
3.7
4.4
%
28.6
21.0
3.80
53
468
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
28
291
0.96
0.04
1.9
1.8
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
312
3106
1.02
0.04
6.5
4.5
mmol/l
6.1
6.0
1.30
296
2836
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
73
718
1.02
0.03
3.5
3.0
ug/l
1.3
0.8
1.06
57
471
(3000764) Benzodiazepines [Presence] in Urine
10
93
1.08
0.02
1.5
1.4
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
10
94
1.07
0.01
1.5
1.4
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
10
94
1.07
0.01
1.5
1.4
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
32
326
0.98
0.00
2.0
2.0
—
—
—
0
0
(3008898) HLA-B27 [Presence]
13
128
1.02
0.00
1.0
1.1
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
18
183
0.98
0.00
1.2
1.2
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
10
95
1.05
0.00
1.5
1.4
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
5
50
1.00
0.00
1.0
1.1
—
—
—
0
0
(3024869) Neuronal Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
5
52
0.96
0.00
1.4
1.2
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
5
59
0.85
0.00
1.8
1.6
—
—
—
0
0
(3000285) Sodium [Moles/volume] in Blood
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3042299) inFLIXimab [Mass/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
5.1
—
5.8
—
0
8
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
7
77
0.91
0.00
1.9
1.5
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3018851) Theophylline [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.3
—
38.7
—
0
6
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
8
83
0.96
0.00
1.5
1.4
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
3.5
—
—
—
0
0
(3004446) Plasmodium sp identified in Blood by Light microscopy
0
5
0.00
0.00
0.0
3.0
—
—
—
0
0
(3027231) Wheat IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.1
—
5.7
—
0
9
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3021162) Amylase [Enzymatic activity/volume] in Specimen
0
6
0.00
0.00
0.0
2.2
—
9122.2
—
0
6
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
0
7
0.00
0.00
0.0
1.0
—
21.4
—
0
7
(3044290) Cell count panel - Cerebral spinal fluid
6
61
0.98
0.00
1.3
1.3
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3022411) Androstenedione [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
8.1
—
0
5
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
8
82
0.98
0.00
1.9
1.3
—
—
—
0
0
(4306422)
5
49
1.02
0.00
1.4
1.3
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
0
6
0.00
0.00
0.0
1.5
—
1.8
—
0
6
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3011544) Albumin [Mass/volume] in Pleural fluid
0
7
0.00
0.00
0.0
1.0
—
18.0
—
0
7
Mortality – FinRegistry
↥Association
Association between endpoint N14_ISOLPROTEINURIA and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| N14_ISOLPROTEINURIA | 2.374 [1.89, 2.99] | < 0.001 |
| Birth year | 0.997 [0.99, 1.01] | 0.498 |
During the follow-up period (1.1.1998 — 31.12.2019), 298 out of 1035 females with N14_ISOLPROTEINURIA died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| N14_ISOLPROTEINURIA | 2.47 [2.05, 2.98] | < 0.001 |
| Birth year | 0.987 [0.98, 1.0] | 0.007 |
During the follow-up period (1.1.1998 — 31.12.2019), 335 out of 1068 males with N14_ISOLPROTEINURIA died.
Mortality risk
Mortality risk for people of age
years, who have N14_ISOLPROTEINURIA.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.206% | 0.406% |
| 5 | 1.226% | 2.37% |
| 10 | 3.842% | 6.592% |
| 15 | 7.307% | 12.895% |
| 20 | 13.146% | 21.264% |
Relationships between endpoints
↥Index endpoint: N14_ISOLPROTEINURIA – Isolated proteinuria with specified morphological lesion
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data